We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement
Analytical Cannabis Logo
×

New Rat Study May Explain How LSD Triggers Hallucinations

Under the influence of LSD, the rats ran less and displayed less neuronal activity in their hippocampi.

Read More

Detroit Votes to Decriminalize Psilocybin and Other Psychedelics

Under the new measure, “the personal possession and therapeutic use of Entheogenic Plants by adults” with become “the city’s lowest law-enforcement priority.”

Read More

“I’ve Never Seen Anything as Effective”: Exploring the Combination of Psychedelics and Psychotherapy

“Ketamine is helpful as a medicine, but there’s so much more to be gained by adding the psychotherapy component,” says Dr Reid Robison, Novamind’s chief medical officer.

Read More

Taking a Chemistry-Led, Patient-Centric Approach to Psychedelic Medicine

Led by experienced natural products chemists, Psilera Bioscience is on a mission to create new, next-generation psychedelic medicines that can better serve patients’ needs.

Read More

Medicinal Genomics Publishes Genome of Psilocybe Cubensis

Scientists at Medicinal Genomics have published a peer-reviewed, highly-contiguous reference genome for the psychedelic mushroom species Psilocybe cubensis.

Read More

Psilocybin Can Enhance How People Emotionally Connect to Music

Taking psilocybin can affect one’s emotional state when listening to music, according to new research presented earlier this month.

Read More

Can Ketamine Relieve Injury Pain?

To address this, two British ambulance services are now participating in a new trial to investigate whether ketamine injections may be a more effective relief treatment for severe injury pain than the current treatment options available to Britain’s first responders.

Read More

Can Psilocybin Help Smokers Quit? This Clinical Trial Aims to Find Out

Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.

Read More

Seattle Decriminalizes Psilocybin and Other Psychedelics

The US city of Seattle has become the largest city in the country to decriminalize the use of some psychedelic substances, including psilocybin and mescaline.

Read More

 
Advertisement